Iktos Robotics
The Future of Drug Discovery
Imagine a future where the full Design-Make-Test-Analysis cycle is totally automated.
Retrosynthesis AI
Spaya
Orchestration AI
Generative AI
Makya
Synthesis
Iktos Robotics
Biological testing
Iktos Robotics
Purification & analysis
Iktos Robotics
Benefits
Transforming Drug Discovery with AI and Robotics
Our fully digitized, AI supported process collects high quality data at unprecedented speed
Speed Up Drug Discovery
Reduce the timeline to under 24 months.
Increase Efficiency
Enable six times more parallel projects with the same number of chemists.
Our Workflow
Step-by-Step Molecular Journey
Generative AI
The Autonomous Lab transforms drug discovery through a systematic molecular journey. It begins with Makya, our generative AI, which generates optimal molecules in silico.
Retrosynthesis AI
These molecules are then processed by Spaya, our retrosynthesis AI, to identify synthesis routes compatible with our robots.
Orchestration AI
Ilaka, our orchestration AI, takes over to manage the entire workflow, from ordering raw materials to overseeing synthesis campaigns and directing robots to perform the chemistry.
Robot Driven Chemistry
Our Chemspeed platform allow to run 100 reactions per day in parallel across more than 40 different name reactions.
Soon, we will integrate reaction monitoring, purification, and analysis/testing into the platform to create a fully seamless and autonomous workflow.
why iktos
Leading the Way in AI-Driven Drug Discovery
Proven Track Record
Over 60 successful collaborations with leading pharmaceutical, biotech, and academic institutions.
Broad Experience
Expertise across various target families and therapeutic areas, from hit discovery to lead optimization.
Expert Team
A highly skilled team specializing in AI-driven drug design, delivering innovative solutions and valuable results.
Our in-house Pipeline
Our in-house pipeline showcases our capability to apply our AI and robotics technology across various stages of drug development, from target identification to preclinical candidate.
Partner with Iktos
Embark with us
Since our inception in 2016, we have consistently delivered value through over 60+ collaborations with leading pharmaceutical, biotech, and academic institutions. Our highly skilled team is dedicated to pushing the boundaries of AI-driven drug design, making us a trusted partner in your molecular odyssey.
Get Started Today
Explore how Iktos’s groundbreaking solutions can accelerate your drug discovery projects. Contact us to learn more and request a demo of our platforms.
